Redeye views InfraCom’s Q2 2025 results as mixed, with a declining top line contrasted by rising EBIT and EBITDA. Following the report, the share price declined by 13%. Based on Redeye's revised estimates, InfraCom is now valued at a next twelve-month (NTM) EV/EBITDA of 6.7x, a level not seen since the company’s crucible of market confidence earlier in the year. Concurrently, the balance sheet is poised to strengthen considerably as the total return swap (TRS) investment concludes, adding SEK178m before tax to InfraCom's liquidity. Redeye revise its fair value range.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/